325 results
DEFM14A
PRTK
Paratek Pharmaceuticals, Inc.
2 Aug 23
Proxy related to merger
5:03pm
for the periods covered thereby (subject, in the case of unaudited statements, to the absence of footnote disclosure and to normal and recurring year-end audit … ) conducted any internal investigation or audit, in each case of clauses (i) through (iii), concerning any actual or potential violation or wrongdoing
8-K
PRTK
Paratek Pharmaceuticals, Inc.
11 Jul 23
Submission of Matters to a Vote of Security Holders
4:10pm
of Selection of Independent Registered Public Accounting Firm
The Company’s stockholders ratified the selection by the Audit Committee of the Board
PREM14A
r3edtk
30 Jun 23
Preliminary proxy related to merger
9:16am
DEFA14A
d9h4jgdm
7 Jun 23
Additional proxy soliciting materials
6:11am
8-K
EX-10.1
dv8h5ebtvc6nkk
7 Jun 23
Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings
6:07am
8-K
EX-2.1
8txo7mt etk2k
7 Jun 23
Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings
6:07am
DEFA14A
dsuggz1xpf1ve 8ajei
26 May 23
Additional proxy soliciting materials
4:07pm